In this context, CYP21A2 enzyme is the most frequently affected in patients with congenital adrenal hyperplasia (CAH), leading to an excessive response of 17-hydroxyprogesterone (17OHP) to ACTH1-24. Here, CYP21A2 is linked to congenital adrenal hyperplasia.